1. Home
  2. AMBO vs CANF Comparison

AMBO vs CANF Comparison

Compare AMBO & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$1.98

Market Cap

6.5M

Sector

Real Estate

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.15

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
CANF
Founded
2000
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.0M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
AMBO
CANF
Price
$1.98
$3.15
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
5.7K
97.9K
Earning Date
08-05-2025
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
N/A
EPS
0.01
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
$286.49
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.17
52 Week High
$6.75
$10.40

Technical Indicators

Market Signals
Indicator
AMBO
CANF
Relative Strength Index (RSI) 38.35 49.56
Support Level $2.01 $3.18
Resistance Level $2.55 $3.60
Average True Range (ATR) 0.12 0.16
MACD -0.01 -0.01
Stochastic Oscillator 45.24 27.38

Price Performance

Historical Comparison
AMBO
CANF

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: